The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
LDL-Apheresis Atherosclerosis Regression Study (LAARS): Effect of Aggressive Versus Conventional Lipid Lowering Treatment on Coronary Atherosclerosis
Open accessAbstract
Background Intensive lipid lowering may retard the progression of coronary atherosclerosis. LDL-apheresis has the potential to decrease LDL cholesterol to very low levels. To assess the effect of more aggressive lipid lowering with LDL-apheresis, we set up a randomized study in men with hypercholesterolemia and severe coronary atherosclerosis. Methods and Results For 2 years, 42 men were treated with either biweekly LDL-apheresis plus medication or medication alone. In both groups a dose of simvastatin of 40 mg per day was administered. Baseline (mean±SD) LDL cholesterol was 7.8±1.9 mmol·L −1 and 7.9±2.3 mmol·L −1 in the apheresis and medication groups, respectively. The mean reduction in LDL cholesterol was 63% (to 3.0 mmol·L −1 ) and 47% (to 4.1 mmol·L −1 ), respectively. Primary quantitative coronary angiographic end points were changes in average mean segment diameter and minimal obstruction diameter. No differences between the apheresis and medication groups were found in mean segment diameter (−0.01±0.16 mm versus 0.03±0.16 mm, respectively) or in minimal obstruction diameter (−0.01±0.13 mm versus 0.01±0.11 mm, respectively), expressed as means per patient. On the basis of coronary segment, mean percent stenosis of all lesions showed a tendency to decrease; only in the apheresis group more minor lesions disappeared in comparison to the medication group. On bicycle exercise tests, the time to 0.1 mV ST-segment depression increased significantly by 39% and the maximum level of ST depression decreased significantly by 0.07 mV in the apheresis group versus no changes in the medication group. Conclusions Two years of lipid lowering both with medication alone or LDL-apheresis with medication showed angiographic arrest of the progression of coronary artery disease. However, more aggressive treatment induced functional improvement, which may precede anatomic changes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Austen, W., Edwards, J., Frye, R., Gensini, G., Gott, V., Griffith, L., McGoon, D., Murphy, M., & Roe, B. (1975) · Circulation · doi:10.1161/01.cir.51.4.5 · Cited by 3,256
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
Blankenhorn, D. H. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390230069027 · Cited by 1,655
Treasure, C. B., Klein, J. L., Weintraub, W. S., Talley, J. D., Stillabower, M. E., Kosinski, A. S., Zhang, J., Boccuzzi, S. J., Cedarholm, J. C., & Alexander, R. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320801 · Cited by 1,097
Stampfer, M. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110036029 · Cited by 1,079
&NA; (1996) · Journal of Occupational & Environmental Medicine · doi:10.1097/00043764-199605000-00005 · Cited by 1,070
Haskell, W. L., Alderman, E. L., Fair, J. M., Maron, D. J., Mackey, S. F., Superko, H. R., Williams, P. T., Johnstone, I. M., Champagne, M. A., & Krauss, R. M. (1994) · Circulation · doi:10.1161/01.cir.89.3.975 · Cited by 884
Watts, G. F., Lewis, B., Lewis, E. S., Coltart, D. J., Smith, L. D. R., Swan, A. V., Brunt, J. N. H., & Mann, J. I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90863-x · Cited by 843
Jukema, J. W., Bruschke, A. V. G., van Boven, A. J., Reiber, J. H. C., Bal, E. T., Zwinderman, A. H., Jansen, H., Boerma, G. J. M., van Rappard, F. M., & Lie, K. I. (1995) · Circulation · doi:10.1161/01.cir.91.10.2528 · Cited by 842
Self-citationKane, J. P. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450230043027 · Cited by 829
Reiber, J. H., Serruys, P. W., Kooijman, C. J., Wijns, W., Slager, C. J., Gerbrands, J. J., Schuurbiers, J. C., den Boer, A., & Hugenholtz, P. G. (1985) · Circulation · doi:10.1161/01.cir.71.2.280 · Cited by 829
Self-citationBrown, B. G., Zhao, X. Q., Sacco, D. E., & Albers, J. J. (1993) · Circulation · doi:10.1161/01.cir.87.6.1781 · Cited by 821
Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease
Boers, G. H. J., Smals, A. G. H., Trijbels, F. J. M., Fowler, B., Bakkeren, J. A. J. M., Schoonderwaldt, H. C., Kleijer, W. J., & Kloppenborg, P. W. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131201 · Cited by 732
Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
Levine, G. N., Keaney, J. F., & Vita, J. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320807 · Cited by 672
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
MAAS Investigators (1994) · The Lancet · doi:10.1016/s0140-6736(94)92082-6 · Cited by 647
Blankenhorn, D. H., Azen, S. P., Kramsch, D. M., Mack, W. J., Cashin-Hemphill, L., Hodis, H. N., DeBoer, L. W. V., Mahrer, P. R., Masteller, M. J., Vailas, L. I., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00002 · Cited by 637
Waters, D., Higginson, L., Gladstone, P., Kimball, B., Le May, M., Boccuzzi, S. J., & Lespérance, J. (1994) · Circulation · doi:10.1161/01.cir.89.3.959 · Cited by 499
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up
Cashin-Hemphill, L. (1990) · JAMA · doi:10.1001/jama.264.23.3013 · Cited by 493
Prognostic significance of progression of coronary atherosclerosis.
Waters, D., Craven, T. E., & Lespérance, J. (1993) · Circulation · doi:10.1161/01.cir.87.4.1067 · Cited by 277
Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia.
Yokoyama, S., Hayashi, R., Satani, M., & Yamamoto, A. (1985) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.5.6.613 · Cited by 250
Thompson, G. R., Maher, V. M. G., Kitano, Y., Neuwirth, C., Maher, V. M. G., Davies, G., Matthews, S., Shortt, M. B., Rees, A., Mir, A., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92961-4 · Cited by 247
George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal.
Blankenhorn, D. H., & Hodis, H. N. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.2.177 · Cited by 224
A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein.
Demacker, P. N., Hijmans, A. G., Vos-Janssen, H. E., van't Laar, A., & Jansen, A. P. (1980) · Clinical Chemistry · doi:10.1093/clinchem/26.13.1775 · Cited by 212
de Feyter, P. J., Serruys, P. W., Davies, M. J., Richardson, P., Lubsen, J., & Oliver, M. F. (1991) · Circulation · doi:10.1161/01.cir.84.1.412 · Cited by 185
Superko, H. R., & Krauss, R. M. (1994) · Circulation · doi:10.1161/01.cir.90.2.1056 · Cited by 177
Mabuchi, H., Michishita, I., Takeda, M., Fujita, H., Koizumi, J., Takeda, R., Takada, S., & Oonishi, M. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90089-x · Cited by 176
Bruschke, A. V., Wijers, T. S., Kolsters, W., & Landmann, J. (1981) · Circulation · doi:10.1161/01.cir.63.3.527 · Cited by 176
Self-citationVasoreactivity of the culprit lesion in unstable angina.
Bogaty, P., Hackett, D., Davies, G., & Maseri, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.5 · Cited by 168
Tatamia, R., Inoue, N., Itoh, H., Kishino, B.-I., Koga, N., Nakashima, Y., NISHIDE, T., Okamura, K., Saito, Y., Teramoto, T., et al. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90170-l · Cited by 154
Schuff‐Werner, P., Gohlke, H., Bartmann, U., Baggio, G., Corti, M. C., Dinsenbacher, A., Eisenhauer, T., Grützmacher, P., Keller, C., Kettner, U., et al. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb01068.x · Cited by 150
Lichtlen, P. R., Nikutta, P., Jost, S., Deckers, J. W., Wiese, B., & Rafflenbeul, W. (1992) · Circulation · doi:10.1161/01.cir.86.3.828 · Cited by 119
Functional improvement precedes structural regression of atherosclerosis.
Benzuly, K. H., Padgett, R. C., Kaul, S., Piegors, D. J., Armstrong, M. L., & Heistad, D. D. (1994) · Circulation · doi:10.1161/01.cir.89.4.1810 · Cited by 106
Quantitative computer techniques for analyzing coronary arteriograms
Brown, B. G., Bolson, E. L., & Dodge, H. T. (1986) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(86)90024-1 · Cited by 106
Gordon, B. R., Kelsey, S. F., Bilheimer, D. W., Brown, D. C., Dau, P. C., Gotto, A. M., Illingworth, D. R., Jones, P. H., Leitman, S. F., Prihoda, J. S., et al. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90352-y · Cited by 95
ADRENAL FUNCTION IN MALNUTRITION
Alleyne, G. A. O., & Young, V. (1966) · The Lancet · doi:10.1016/s0140-6736(66)91584-4 · Cited by 89
Apstein, C. S., Zilversmit, D. B., Lees, R. S., & George, P. K. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90157-0 · Cited by 86
Quantitative coronary arteriography: equipment and technical requirements
Reiber, J. H. C., van der Zwet, P. M. J., Land, C. D. V., Koning, G., van Meurs, B., Buis, B., & van Voorthuisen, A. E. (1993) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1854-5_5 · Cited by 82
Self-citationSimvastatin: The clinical profile
Walker, J. F. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80598-4 · Cited by 78
Clinical-pathological correlations of coronary disease progression and regression.
Fuster, V., Badimón, J. J., & Badimón, L. (1992) · PubMed · Cited by 72
Reiber, J. H. C., Land, C. D. V., Koning, G., van der Zwet, P. M. J., Houdt, R. C. M. V., Schalij, M. J., & Lespérance, J. (1994) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1172-0_5 · Cited by 67
Self-citationPfohl, M., Naoumova, R. P., Klass, C. M., Knisel, W., Jakober, B., Risler, T., & Thompson, G. R. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39941-7 · Cited by 65
Immunonephelometric assay of human apolipoprotein AI.
Lopes-Virella, M. F., Virella, G., Evans, G., Malenkos, S. B., & Colwell, J. A. (1980) · Clinical Chemistry · doi:10.1093/clinchem/26.8.1205 · Cited by 61
Retardation and arrest of progression or regression of coronary artery disease: A review
Vos, J., de Feyter, P. J., Simoons, M. L., Tijssen, J. G. P., & Deckers, J. W. (1993) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(93)90028-c · Cited by 59
Knisel, W., di Nicuolo, A., Pfohl, M., Müller, H.-H., Risler, T., Eggstein, M., & Seifried, E. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00781.x · Cited by 56
Koizumi, J., Koizumi, I., Uno, Y., Inazu, A., Kajinami, K., Haraki, T., Yagi, K., KAMON, N., Miyamoto, S., Takegoshi, T., et al. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90068-6 · Cited by 42
Efficacy and tolerability of simvastatin (MK-733)
Stalenhoef, A. F. H., Mol, M. J. T. M., & Stuyt, P. M. J. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80597-2 · Cited by 39
Self-citationACE inhibitors and LDL-apheresis with dextran sulphate adsorption
Kroon, A. A., Mol, M. J., & Stalenhoef, A. F. (1992) · The Lancet · doi:10.1016/0140-6736(92)92673-4 · Cited by 34
Self-citationRegression of atherosclerosis in humans by lowering serum cholesterol
Yamamoto, A. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90002-k · Cited by 34
Advances in LDL-apheresis for the treatment of severe hypercholesterolemia
Gordon, B. R., & Saal, S. D. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199402000-00011 · Cited by 32
Mabuchi, H., Fujita, H., Michishita, I., TAKEDA, M., Kajinami, K., Koizumi, J., Takeda, R., Takegoshi, T., WAKASUGI, T., Ueda, K., et al. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90079-2 · Cited by 17
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
Goldberg, A. C., Hopkins, P. N., Toth, P. P., Ballantyne, C. M., Rader, D. J., Robinson, J. G., Daniels, S. R., Gidding, S. S., de Ferranti, S. D., Ito, M. K., et al. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.001 · Cited by 622
Schwartz, J., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 603
Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
Civeira, F. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.11.010 · Cited by 495
Metadata
- Authors
- Kroon, A. A., Aengevaeren, W. R. M., van der Werf, T., Uijen, G. J. H., Reiber, J. H. C., Bruschke, A. V. G., & Stalenhoef, A. F. H.
- Venue
- Circulation
- Published
- 1996-05-15
- Volume
- 93
- Issue
- 10
- Pages
- 1826-1835
- ISSN
- 0009-7322
- 1524-4539
- OpenAlex
- W1991899835
- Cited by
- 275
- References
- 53
- FWCI
- 22.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.